Renalytix Plc (RENX.L) LSE
1.80
+0(+0.00%)
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 9.68M |
| Enterprise Value | 14.38M |
| P/E Ratio | -0.33 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 9.85 |
| Price/Book Ratio | -1.43 |
| Enterprise/Revenue | 11.53 |
| Enterprise/EBITDA | -0.93 |
Fiscal Year
| Fiscal Year | June 30, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -14.62 |
| Operating Margin | -12.93 |
Management Effectiveness
| Return On Assets | -4.2 |
| Return On Equity | -6.31 |
Income Statement
| Revenue | 3M |
| Revenue/Share | 0.04 |
| Gross Profit | 1.2M |
| EBITDA | -21.3M |
| Net Income | -20.4M |
| Diluted EPS | -0.21 |
Balance Sheet
| Total Cash | 6.2M |
| Total Cash/Share | 0.09 |
| Total Debt | 5.8M |
| Total Debt/Equity | -1.09 |
| Current Ratio | 0.53 |
| Book Value Per Share | -0.15 |
Price History
| 52-Week Change | -75.17 |
| 52-Week High | 15.5 |
| 52-Week Low | 1.6 |
| Moving Average 50 Days | 1.92 |
| Moving Average 200 Days | 5.22 |
Statistics
| Average Volume | 914,031 |
| Shares Outstanding | 366.67M |
| % Held by Institutions | 0.24 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
